发明授权
US08058009B2 Target protein and target gene in drug designing and screening method
失效
靶蛋白和靶基因在药物设计筛选中的应用
- 专利标题： Target protein and target gene in drug designing and screening method
- 专利标题（中）： 靶蛋白和靶基因在药物设计筛选中的应用
-
申请号： US11718946申请日： 2005-11-09
-
公开(公告)号： US08058009B2公开(公告)日： 2011-11-15
- 发明人: Yorimasa Suwa , Tadakazu Yamauchi , Tsuyoshi Yamada , Hironori Oosaki , Morikazu Kito
- 申请人： Yorimasa Suwa , Tadakazu Yamauchi , Tsuyoshi Yamada , Hironori Oosaki , Morikazu Kito
- 申请人地址： JP Tokyo
- 专利权人： Reverse Proteomics Research Institute Co., Ltd.
- 当前专利权人： Reverse Proteomics Research Institute Co., Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Leydig, Voit & Mayer, Ltd.
- 优先权： JP2004-325537 20041109
- 国际申请： PCT/JP2005/020989 WO 20051109
- 国际公布： WO2006/052000 WO 20060518
- 主分类号： G01N33/53
- IPC分类号： G01N33/53
摘要：
The present invention provides target proteins and target genes for bioactive substances such as drugs, and means that enable the development of novel bioactive substances using the same. To be specific, the present invention provides target proteins and target genes for bioactive substances; screening methods for substances capable of regulating bioactivities; bioactivity regulators; a bioactive substance derivative production method; a complex comprising a bioactive substance and a target protein, and a method of producing the complex; and kits comprising a bioactive substance or a salt thereof; determination methods for the onset or risk of onset of a specified disease or condition, determination methods for susceptibility to a bioactive substance, and determination kits used for the determination methods, and the like.
公开/授权文献
信息查询
IPC分类:
